University of Michigan Comprehensive Cancer CenterDivision of Hematology/Oncology is a clinical research site located in Ann Arbor, Michigan, United States 48109.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
University of Michigan Comprehensive Cancer CenterDivision of Hematology/Oncology has participated in 1 clinical trials.
Therapeutic areas: Multiple Myeloma.
Sponsors: Celgene Corporation.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Michigan Comprehensive Cancer CenterDivision of Hematology/Oncology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Michigan Comprehensive Cancer CenterDivision of Hematology/Oncology has 1 clinical trials on record. Their work covers Multiple Myeloma.
University of Michigan Comprehensive Cancer CenterDivision of Hematology/Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.